MedTrace Logo

Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD)

NCT00308698 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2006-03-30

No results posted yet for this study

Summary

High recombinant human erythropoietin requirement and elevated serum adiponectin were significant determinants of long-term mortality in patients who started hemodialysis therapy.

Conditions

  • Renal Dialysis

Sponsors & Collaborators

  • Fujinomiya City Hospital

    collaborator OTHER

  • Iwata City Hospital

    collaborator OTHER

  • Seirei Mikatabara General Hospital

    collaborator UNKNOWN

  • Seirei Hamamatsu General Hospital

    collaborator OTHER

  • Hamana Clinic

    collaborator OTHER

  • Tadokoro Clinic

    collaborator UNKNOWN

  • Makoto Clinic

    collaborator UNKNOWN

  • Maruyama Memorial General Hospital

    collaborator OTHER

  • Shitoro Clinic

    collaborator UNKNOWN

  • Sun-Sanaru Clinic

    collaborator UNKNOWN

  • Hamamatsu University

    lead OTHER

Principal Investigators

  • Naro Ohashi, M.D., Ph.D. · First Department of Medicine, Hamamatsu University School of Medicine

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308698 on ClinicalTrials.gov